0MGB.LSE News | Roxom Stocks

1 BTC

=

- USD

Loading market data...

0M

Mkt Cap

N/A

Volume

N/A

Next Earnings

N/A

Chart Earnings News About Insider Filings

Transactions in Connection with Share Buy-back ProgramGenmab A/S Company Announcement COPENHAGEN, Denmark; April 22, 2025 – Genmab A/S (Nasdaq: GMAB). On March 25, 2025, Genmab announced the initiation of a share buy-back program to repurchase up to 2.2 million shares to reduce capital and to honor our commitments under the Restrict…finance.yahoo.com · Apr 22, 2025

Genmab (CPSE:GMAB) Reports US$3 Billion DARZALEX Sales For Q1 2025Genmab recently reported impressive first-quarter 2025 trade sales for DARZALEX, totaling USD 3,237 million, with strong performance both in the U.S. and internationally. Over the past week, the stock price increased by 1.93%, a movement aligned with broader market trends which s…finance.yahoo.com · Apr 15, 2025

Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2025Genmab A/S Company Announcement Net sales of DARZALEX® in the first quarter of 2025 totaled USD 3,237 million Genmab receives royalties on worldwide net sales from Johnson & Johnson (J&J, legal entity Janssen Biotech, Inc.) COPENHAGEN, Denmark; April 15, 2025 – Genmab A/S (Nasdaq…finance.yahoo.com · Apr 15, 2025

Transactions in Connection with Share Buy-back ProgramGenmab A/S Company Announcement COPENHAGEN, Denmark; April 14, 2025 – Genmab A/S (Nasdaq: GMAB). On March 25, 2025, Genmab announced the initiation of a share buy-back program to repurchase up to 2.2 million shares to reduce capital and to honor our commitments under the Restrict…finance.yahoo.com · Apr 14, 2025

Genmab A/S Share Capital ReductionGenmab A/S Company Announcement COPENHAGEN, Denmark; April 10, 2025 – Genmab A/S (Nasdaq: GMAB) At Genmab A/S’ Annual General Meeting on March 12, 2025, it was decided to reduce the Company’s share capital with nominally DKK 2,076,853 by cancellation of 2,076,853 of the Company’s…finance.yahoo.com · Apr 10, 2025

Transactions In Connection with Share Buy-back ProgramGenmab A/S Company Announcement COPENHAGEN, Denmark; April 7, 2025 – Genmab A/S (Nasdaq: GMAB). On March 25, 2025, Genmab announced the initiation of a share buy-back program to repurchase up to 2.2 million shares to reduce capital and to honor our commitments under the Restricte…finance.yahoo.com · Apr 7, 2025

Transactions With Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated PersonsGenmab A/S Company Announcement COPENHAGEN, Denmark; April 1, 2025 – Genmab A/S (Nasdaq: GMAB) – In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document discloses the data of the transactions made in Genmab A/S …finance.yahoo.com · Apr 1, 2025

TIVDAK® (tisotumab vedotin) Approved by European Commission for Previously Treated Recurrent or Metastatic Cervical CancerTIVDAK® is the first and only antibody-drug conjugate (ADC) approved to treat recurrent or metastatic cervical cancer with disease progression on or after systemic therapy In the global Phase 3 innovaTV 301 clinical trial TIVDAK demonstrated superior overall survival compared to …finance.yahoo.com · Mar 31, 2025

Transactions in connection with share buy-back programGenmab A/S Company Announcement COPENHAGEN, Denmark; March 31, 2025 – Genmab A/S (Nasdaq: GMAB). On March 25, 2025, Genmab announced the initiation of a share buy-back program to repurchase up to 2.2 million shares to reduce capital and to honor our commitments under the Restrict…finance.yahoo.com · Mar 31, 2025

TIVDAK® (tisotumab vedotin) Approved by Japan Ministry of Health, Labour and Welfare for the Treatment of Advanced or Recurrent Cervical Cancer that has Progressed on or after ChemotherapyTIVDAK® is the first and only antibody-drug conjugate (ADC) approved for patients with advanced or recurrent cervical cancer in Japan Approval is based on results from the global Phase 3 innovaTV 301 trial, in which TIVDAK demonstrated superior overall survival compared to chemot…finance.yahoo.com · Mar 27, 2025

0M

0MGB.LSE0MGB.LSE

0MGB.LSE

Pay with—

Available Balance0.00

Your PositionYou don't own any 0MGB.LSE yet.

Related Tickers

Earnings